These tests are non-invasive and provide valuable information for tracking changes over time
Changes in color may indicate degradation or contamination and the medication should not be used
Venter H, Genade S, Mouton R, Huisamen B, Harper IS, Lochner A
Retatrutide is a triple agonist (GLP-1 + GIP + glucagon) still in Phase 3 trials, marketed as more effective than Tirzepatides dual mechanism
In addition to the hot flashes and night sweats typical of women going through menopause, perimenopausal or menopausal women who may also have a growth hormone deficiency may experience: Insomnia Dryness and thinning of the skin and particularly of the vaginal area Weight gain, particularly belly fat Lack of energy Lack of ability to build muscle Weakened immune response Diminished sex drive and loss of sensitivity to stimulation Hair Loss Anxiety Forgetfulness that may include an increase of Alzheimers disease Depression and other mood changes Symptoms also include the potential loss of bone density and increased risk of heart disease
Mycoplasma testing was performed yearly
